Alcon Inc.

ALC ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2010 FY2009 FY2008 FY2007
Revenue $6.79B $7.18B $6.50B $6.29B $5.60B
Cost of Revenue $3.59B $1.68B $1.61B $1.47B $1.40B
Gross Profit $3.20B $5.50B $4.89B $4.82B $4.20B
Gross Margin 47.2% 76.7% 75.2% 76.6% 75.0%
Operating Expenses
Research & Development — $747.0M $665.0M $619.0M $564.0M
SG&A Expense — — — — —
Operating Income $-77.0M $2.48B $2.26B $2.21B $1.88B
Operating Margin -1.1% 34.5% 34.8% 35.2% 33.6%
Interest Expense $27.0M $9.0M $16.0M $51.0M $50.0M
Pretax Income $-127.0M $2.53B $2.31B $2.08B $1.93B
Income Tax Expense $-383.0M $317.0M $306.0M $36.0M $343.0M
Net Income $256.0M $2.21B $2.01B $2.05B $1.59B
Net Margin 3.8% 30.8% 30.9% 32.5% 28.3%
EPS (Basic) $0.52 $7.34 $6.72 $6.86 $5.32
EPS (Diluted) $0.52 $7.27 $6.66 $6.79 $5.25
Shares Outstanding (Basic) — 300.9M 298.8M 298.5M —
Shares Outstanding (Diluted) — 304.1M 301.35T 301.58T 302.16T
Dividends Per Share — — — — —
← Newer Page 2 of 2 Older →